Knowledge Base

Does the divided dose of yellow fever vaccine present a greater risk of adverse reactions?

25 December 2023
2 min read

The fractional dose comes from the same full dose vaccine. It has been given to millions of people to prevent yellow fever in the past. It is as safe and as effective as the full dose of the vaccine.

Serious adverse effects following a full dose of yellow fever vaccine are extremely rare (less than one per one million people). There is no evidence of increased serious adverse effects when using a fractional dose.

Fractional dosing is currently being used for inactivated polio vaccine (IPV), Rabies and Bacillus CalmetteGuérin (BCG).

Zenocutuzumab: A Quick Look at Its R&D Progress and Clinical Results from the 2023 ESMO_ASIA
ESMO 2023
4 min read
Zenocutuzumab: A Quick Look at Its R&D Progress and Clinical Results from the 2023 ESMO_ASIA
25 December 2023
Zenocutuzumab (MCLA-128; Zeno) is a bispecific antibody that overcomes HER3-mediated NRG1 signaling in NRG1+ cancer.
Read →
What is Compassionate use in EU?
"What" Series
2 min read
What is Compassionate use in EU?
25 December 2023
In the European Union (EU), Compassionate use is a treatment option that allows the use of an unauthorised medicine.
Read →
Rezolute starts key Phase 3 trial for RZ358 to treat Congenital Hyperinsulinism
Latest Hotspot
3 min read
Rezolute starts key Phase 3 trial for RZ358 to treat Congenital Hyperinsulinism
25 December 2023
Rezolute has commenced a pivotal Phase 3 clinical trial for its investigative drug, RZ358, aimed at treating patients with Congenital Hyperinsulinism.
Read →
What are the open status categories for FDA postmarketing requirements and commitments?
"What" Series
2 min read
What are the open status categories for FDA postmarketing requirements and commitments?
25 December 2023
Here are the open status categories for FDA postmarketing requirements and commitments listed.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.